Articles tagged with Randomization
A study found that two forms of bias in cause-of-death classification affect the results of randomized trials on cancer screening. Sticky-diagnosis bias biases against screening, while slippery-linkage bias biases in favor of screening. The authors suggest using all-cause mortality to accurately assess the value of screening.
The ACCESS study confirms that Atacand improves outcomes for patients with acute ischaemic stroke and high blood pressure. Early treatment with Atacand reduces the risk of total mortality, cerebral complications, and cardiovascular complications by 47.5 percent.
A recent randomized controlled trial suggests that preventing falls among elderly people remains a challenging task. Despite improvements in adherence to interventions, injuries and subsequent harm persist. Researchers emphasize the need for continued research and practice to address this critical public health issue.
A review of patients treated with NIPPV found mortality rates were 28.6% higher in the clinical setting compared to randomized trials. The authors recommend developing practice guidelines to optimize NIPPV use. Dr. Sheldon Magder comments on the limitations of relying heavily on randomized trial findings in clinical settings.
A randomized clinical trial showed that combining bone marrow transplant and high-dose chemoradiotherapy significantly improves disease-free survival in children with neuroblastoma. The addition of vitamin A-derivative treatment further increases survival rates by nearly three-fold.